Skip to main content
. 2009 Feb;4(2):401–409. doi: 10.2215/CJN.02630608

Figure 4.

Figure 4.

Mean serum phosphate values during the current therapy, washout, study, and follow-up periods for the ITT population: primary efficacy variable. (Serum phosphate level during treatment with 1- and 2-g fermagate three times daily was significantly lower than with either washout or in comparison with placebo-treated patients.)